# Amorepacific Corporation clinical trials: 23 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 23 trials with Amorepacific Corporation as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Amorepacific Corporation: 23 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/amorepacific-corporation

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 24, 2024 | NCT06609603 | Clinical Study to Evaluate the Body Fat Reducing Effects of Heat-Treated Green Tea Extract Complex | Amorepacific Corporation | Not applicable | Unknown | Body Fat | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06609603) |
| September 19, 2024 | NCT06592365 | Clinical Study to Evaluate the Effects and Safety of Green Tea Extract on Blood Glucose Regulation | Amorepacific Corporation | Not applicable | Unknown | Blood Sugar | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06592365) |
| May 20, 2024 | NCT06422026 | Evaluated the Efficacy and Safety of APCP on Hair Health | Amorepacific Corporation | Not applicable | Completed | Hair Damage | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06422026) |
| May 20, 2024 | NCT06422013 | Clinical Study to Evaluate the Body Fat Reducing Effect and Safety of GTB1 | Amorepacific Corporation | Not applicable | Completed | Body Fat | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06422013) |
| February 13, 2023 | NCT05725044 | Clinical Trial to Evaluate of Efficacy and Safety of Ginsengberry Concentrate on Fatigue. | Amorepacific Corporation | Not applicable | Completed | Fatigue | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05725044) |
| March 14, 2022 | NCT05277428 | Clinical Study to Evaluate the IBS Symptoms Improving Effect and Safety of GTB1 | Amorepacific Corporation | Not applicable | Completed | Irritable Bowel Syndrome With Diarrhea | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05277428) |
| September 28, 2021 | NCT05059197 | Efficacy and Safety of AP Collagen Peptide on the Skin | Amorepacific Corporation | Not applicable | Completed | Dry Skin | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05059197) |
| April 23, 2021 | NCT04857021 | Clinical Study to Investigate the Sleep Quality Enhancing Effect of GABA | Amorepacific Corporation | Not applicable | Completed | Sleep Disturbance | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04857021) |
| April 20, 2021 | NCT04850352 | Clinical Study to Evaluate the Blood Triglyceride Decreasing Effect and Safety of Korean Post-Fermented Tea Extracts | Amorepacific Corporation | Not applicable | Completed | Triglycerides High | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04850352) |
| April 20, 2021 | NCT04850326 | Clinical Study to Evaluate the Short Time Efficacy of AP Green Tea Extract Affer High Fat, High Carbohydrate Diet | Amorepacific Corporation | Not applicable | Completed | Blood Glucose, High | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04850326) |
| April 9, 2020 | NCT04340375 | Anti-pollution Effects of AP Green Tea Extracts | Amorepacific Corporation | Not applicable | Completed | Respiratory Conditions Due to Unspecified External Agent | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04340375) |
| November 16, 2016 | NCT02965118 | CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis | Amorepacific Corporation | Phase 3 | Completed | Atopic Dermatitis | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02965118) |
| May 2, 2016 | NCT02757729 | A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis | Amorepacific Corporation | Phase 2 | Completed | Atopic Dermatitis | 192 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02757729) |
| April 25, 2016 | NCT02749383 | A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis | Amorepacific Corporation | Phase 2 | Completed | Seborrheic Dermatitis | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02749383) |
| April 22, 2016 | NCT02748993 | A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis | Amorepacific Corporation | Phase 1/2 | Completed | Atopic Dermatitis | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02748993) |
| October 21, 2015 | NCT02583022 | A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis | Amorepacific Corporation | Phase 2 | Completed | Atopic Dermatitis | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02583022) |
| October 21, 2015 | NCT02583009 | A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea | Amorepacific Corporation | Phase 2 | Completed | Rosacea | 216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02583009) |
| October 1, 2015 | NCT02565134 | A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus | Amorepacific Corporation | Phase 2 | Completed | Skin Pruritus | 296 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02565134) |
| December 5, 2014 | NCT02309008 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream in Healthy Male Subjects | Amorepacific Corporation | Phase 1 | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02309008) |
| February 3, 2014 | NCT02052999 | Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients | Amorepacific Corporation | Phase 2 | Completed | Erythematotelangiectatic Rosacea, Papulopustular Rosacea | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02052999) |
| February 3, 2014 | NCT02052531 | Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus | Amorepacific Corporation | Phase 2 | Completed | Skin Pruritus | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02052531) |
| July 11, 2012 | NCT01638117 | Cumulative Irritation Test of PAC-14028 in Healthy Volunteers | Amorepacific Corporation | Phase 1 | Completed | Healthy | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01638117) |
| December 21, 2010 | NCT01264224 | PAC-14028 in Healthy Male Volunteers | Amorepacific Corporation | Phase 1 | Completed | Healthy | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01264224) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 3 |
| Phase 1/2 | 1 |
| Phase 2 | 7 |
| Phase 3 | 1 |
| Not applicable | 11 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 21 |
| Unknown | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Dermatitis, Atopic | 4 |
| Rosacea | 2 |
| Dermatitis, Seborrheic | 1 |
| Fatigue | 1 |
| Parasomnias | 1 |
| Hypertriglyceridemia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Bathtub and sink repair companies in the United States](https://specstream.ai/data/businesses/bathtub-and-sink-repair-companies/united-states)
- [B2B secretarial companies in the United States](https://specstream.ai/data/businesses/b2b-secretarial-companies/united-states)
- [B2B food products companies in the United States](https://specstream.ai/data/businesses/b2b-food-products-companies/united-states)
- [Australian restaurants in the United States](https://specstream.ai/data/businesses/australian-restaurants/united-states)
- [Antenna companies in the United States](https://specstream.ai/data/businesses/antenna-companies/united-states)
- [Advertising agencies in the United States](https://specstream.ai/data/businesses/advertising-agencies/united-states)
